JP2001013136A - Histamine measuring method and histamine measuring device - Google Patents
Histamine measuring method and histamine measuring deviceInfo
- Publication number
- JP2001013136A JP2001013136A JP11184740A JP18474099A JP2001013136A JP 2001013136 A JP2001013136 A JP 2001013136A JP 11184740 A JP11184740 A JP 11184740A JP 18474099 A JP18474099 A JP 18474099A JP 2001013136 A JP2001013136 A JP 2001013136A
- Authority
- JP
- Japan
- Prior art keywords
- histamine
- measuring
- oocyte
- container
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
- G01F1/00—Measuring the volume flow or mass flow of fluid or fluent solid material wherein the fluid passes through a meter in a continuous flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/808—Optical sensing apparatus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/806—Electrical property or magnetic property
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/826—Additives, e.g. buffers, diluents, preservatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本法は試料、特に血液や細胞
培養液中に存在するヒスタミンを定量する方法を提供す
るためのものである。計測系としては特にヒスタミンの
検出にヒスタミン受容体発現卵母細胞の細胞反応を用い
るものである。TECHNICAL FIELD The present invention is intended to provide a method for quantifying histamine present in a sample, particularly in blood or cell culture. As a measurement system, a cell reaction of a histamine receptor-expressing oocyte is particularly used for detecting histamine.
【0002】[0002]
【従来の技術】ヒスタミン遊離試験法は血液中の白血球
や粘膜組織中の肥満細胞を刺激し、細胞中からヒスタミ
ンを遊離させ、遊離したヒスタミンを定量する方法であ
る。本法はアレルギー疾患についてそのアレルゲンを特
定する方法として報告されている(田部一秋:アレルギ
ーの診断−ヒスタミン遊離試験、SRL宝函Vol.21、No.1-
2、1997)。遊離ヒスタミン測定法に関しては、例えば
特開平6-331619に示されたような蛍光高速液体クロマト
グラフィー(HPLC)法によりヒスタミンを分離後、蛍光
試薬と反応させ、その蛍光量を測定する方法、または特
開平10-62415や特開平10-170514に示されたような遊離
ヒスタミンをガラスファイバーで分離後、蛍光試薬と反
応させ、その蛍光量を測定する方法、さらにICN Pharma
ceuticals社やImmunotech社から販売されている競合ア
ッセイによるELISAなどが知られている。2. Description of the Related Art The histamine release test method is a method of stimulating leukocytes in blood and mast cells in mucosal tissues, releasing histamine from the cells, and quantifying the released histamine. This method has been reported as a method to identify allergens in allergic diseases (Kazuaki Tabe: Diagnosis of allergy-histamine release test, SRL Houka Vol.21, No.1-
2, 1997). Regarding the method for measuring free histamine, for example, histamine is separated by a fluorescent high performance liquid chromatography (HPLC) method as disclosed in JP-A-6-331619 and then reacted with a fluorescent reagent to measure the amount of fluorescence. A method of separating free histamine by a glass fiber as described in Kaihei 10-62415 or JP-A-10-170514, reacting it with a fluorescent reagent, and measuring the amount of fluorescence, furthermore, ICN Pharma
ELISA by competitive assay sold by ceuticals and Immunotech, and the like are known.
【0003】[0003]
【発明が解決しようとする課題】従来の蛍光量測定によ
るヒスタミン遊離試験法では試料中からヒスタミンのみ
を分離し、分離したヒスタミンを標識し、その標識化合
物の量を遊離ヒスタミン量としている。本発明はこの間
接的なヒスタミン定量法に対して、ヒスタミン受容体を
用いることにより直接ヒスタミンを定量する方法を提供
するものである。またヒスタミン受容体を用いることに
より、試料中にヒスタミン誘導体やヒスタミン類似物質
など夾雑物が混入、あるいは非常に微量しかヒスタミン
が含まれていない場合においても、特異性高くヒスタミ
ンを認識する方法を提供するものである。また特異性の
高い受容体を用いることにより試料を精製するなどの煩
雑な操作を必要とせずに簡便にヒスタミンを定量する方
法を提供するものである。さらにヒスタミンを直接認識
することが可能で、特異性の高い受容体を用いることに
より、ヒスタミンの標識、精製などが不要になるためよ
り短い測定時間でヒスタミンを定量する方法を提供する
ものである。In the conventional histamine release test method by measuring the amount of fluorescence, only histamine is separated from a sample, the separated histamine is labeled, and the amount of the labeled compound is defined as the amount of free histamine. The present invention provides a method for directly quantifying histamine by using a histamine receptor in contrast to this indirect histamine quantification method. In addition, by using a histamine receptor, a method for recognizing histamine with high specificity is provided even when a sample is contaminated with a histamine derivative or a histamine analog or a very small amount of histamine is contained. Things. It is another object of the present invention to provide a simple method for quantifying histamine without using complicated receptors such as purifying a sample by using a highly specific receptor. Further, the present invention provides a method for quantifying histamine in a shorter measurement time since histamine can be directly recognized and histamine labeling and purification are not required by using a highly specific receptor.
【0004】さらに検出方法はヒスタミン受容体発現卵
母細胞がヒスタミンを認識した時の細胞の生理的反応を
直接電気信号に変換し行う。細胞反応はミリ秒以下で起
こることが知られており、ヒスタミンの検出時間は1秒
以内で行うことが可能となる。すなわち、他の検出方法
と比較して、極めて迅速にヒスタミンの有無を判断でき
る方法を提供するものである。[0004] Further, a detection method is to directly convert a physiological response of a histamine receptor-expressing oocyte when the oocyte recognizes histamine into an electric signal. Cell reactions are known to occur in milliseconds or less, and histamine can be detected within 1 second. That is, the present invention provides a method capable of judging the presence or absence of histamine extremely quickly as compared with other detection methods.
【0005】ここで一般的にヒスタミン遊離試験に対し
て要求される機能・課題をまとめると、以下の項目に要
約される。[0005] Here, the functions and problems generally required for the histamine release test can be summarized as follows.
【0006】(1)標識化合物ではなく、ヒスタミンを
直接定量できること。(1) Histamine, not a labeled compound, can be directly quantified.
【0007】(2)試料の前処理なしで測定できるこ
と。(2) Measurement can be performed without pretreatment of the sample.
【0008】(3)迅速に結果が得られること。(3) The results can be obtained quickly.
【0009】(4)特異性の高い測定方法であること。(4) A highly specific measurement method.
【0010】そこで本発明は以上に述べた課題を達成す
るためのヒスタミン遊離試験法を提供することを目的と
するものである。Accordingly, an object of the present invention is to provide a histamine release test method for achieving the above-mentioned object.
【0011】[0011]
【課題を解決するための手段】本発明のヒスタミン遊離
試験法は予めヒスタミン受容体を発現させた細胞に対し
抗原刺激後の全血を添加し、その細胞反応を検出するこ
とから成っている。採血された全血に抗原を一定量添加
し、10-30分間程度、37℃で反応させる。なお、反応時
間はあくまでも目安にすぎず、アレルギー反応の最適化
により変る場合がある。この際、軽く振とうさせること
が望ましい。この間にヒスタミン受容体発現細胞を既知
の複数の濃度のヒスタミンで刺激し、細胞の反応量とヒ
スタミン濃度間の濃度−応答曲線(検量線)を求めてお
く。抗原刺激後の全血でヒスタミン受容体発現細胞を刺
激しその反応量を検量線にあてはめ、抗原刺激後の全血
に含まれるヒスタミン濃度を定量する。なおヒスタミン
遊離率は抗原刺激後の全血のヒスタミン濃度を全血を凍
結融解することにより、血中の細胞に含まれるヒスタミ
ンを放出させた全血に含まれるヒスタミン濃度を定量し
た値で割ることによって求める。また抗原の代わりに緩
衝液を加えて、同一条件下においた全血を用いて血液中
の細胞からのヒスタミンの自然遊離濃度を求める(コン
トロール)。この手法を用いることにより20-50分間程
度でヒスタミン遊離試験を行うことが可能になる。The histamine release test method of the present invention comprises adding whole blood after antigen stimulation to cells in which a histamine receptor has been previously expressed, and detecting the cell response. A certain amount of an antigen is added to the collected whole blood, and the mixture is reacted at 37 ° C. for about 10 to 30 minutes. The reaction time is only a guide and may be changed by optimizing an allergic reaction. At this time, it is desirable to shake lightly. During this time, the histamine receptor-expressing cells are stimulated with a plurality of known concentrations of histamine, and a concentration-response curve (calibration curve) between the reaction amount of the cells and the histamine concentration is determined. The histamine receptor-expressing cells are stimulated with whole blood after antigen stimulation, and the amount of the reaction is fitted to a calibration curve to determine the histamine concentration contained in whole blood after antigen stimulation. The histamine release rate is obtained by dividing the histamine concentration of whole blood after antigen stimulation by quantifying the histamine concentration contained in whole blood obtained by releasing histamine contained in blood cells by freezing and thawing whole blood. Ask by. Further, a buffer solution is added instead of the antigen, and the spontaneous free concentration of histamine from cells in the blood is determined using whole blood under the same conditions (control). By using this method, a histamine release test can be performed in about 20 to 50 minutes.
【0012】[0012]
【発明の実施の形態】本発明のヒスタミン遊離試験法は
予めヒスタミン受容体を発現させた細胞に対し抗原刺激
後の全血を添加し、その細胞反応を検出することから成
っている。以下では細胞反応検出法としてヒスタミン受
容体を介する塩素イオンチャネルの応答の電気生理学的
検出法を用いて説明するが、必ずしも塩素イオンチャネ
ル応答や電気生理学的検出法に限定されるべきものでは
なく、特開平9-242377に示したようにその他の受容体刺
激に由来する細胞応答やその検出方法を含むものであ
る。BEST MODE FOR CARRYING OUT THE INVENTION The histamine release test method of the present invention comprises adding whole blood after antigen stimulation to cells in which a histamine receptor has been expressed in advance, and detecting the cell response. In the following, a description will be given using an electrophysiological detection method of the response of the chloride ion channel through the histamine receptor as a cell reaction detection method, but is not necessarily limited to the chloride ion channel response and the electrophysiological detection method, As described in Japanese Patent Application Laid-Open No. 9-242377, other methods include cell responses derived from stimulation of receptors and methods for detecting the same.
【0013】以下、図面を用いて本発明の実施例を説明
する。An embodiment of the present invention will be described below with reference to the drawings.
【0014】図1はヒスタミン受容体発現卵母細胞を用
いたヒスタミン定量法の概略図である。緩衝液を満たし
た本体部分1にヒスタミン受容体発現卵母細胞2を置く。
3M KClを充填し、塩化銀でコ−ティングした銀線をつな
いだ2本のガラス電極3、4を卵母細胞2に刺入する。電極
3からのリードアウトは外部電極5との電位差として差動
増幅器6、および記録装置7に送られ、記録される。差動
増幅器は、電極3から差動増幅器6に送られたシグナルと
固定電位の差分の電流を電極4を通して卵母細胞に加え
る。このように膜電位固定した卵母細胞にヒスタミン8
をピペット9などにより滴下するとに細胞の電流応答10
を得ることができる。FIG. 1 is a schematic diagram of a histamine quantification method using histamine receptor-expressing oocytes. The histamine receptor-expressing oocyte 2 is placed on the body part 1 filled with the buffer.
Two glass electrodes 3 and 4 connected to a silver wire coated with silver chloride coated with 3 M KCl are inserted into the oocyte 2. electrode
The readout from 3 is sent to the differential amplifier 6 and the recording device 7 as a potential difference from the external electrode 5, and is recorded. The differential amplifier applies a current of a difference between the signal sent from the electrode 3 to the differential amplifier 6 and the fixed potential to the oocyte through the electrode 4. Histamine 8 was added to the oocytes fixed in this way.
Response of the cell by dropping
Can be obtained.
【0015】図2は上記の手法で得られたヒスタミン濃
度と細胞応答の関係について示したものである。ヒスタ
ミン濃度20-200nMの範囲においてヒスタミン濃度と電流
変化量、すなわち細胞の電流変化量は正の相関関係にあ
る。つまり細胞の電流変化量から試料中に含まれるヒス
タミン濃度を求めることができる。FIG. 2 shows the relationship between the histamine concentration obtained by the above method and the cell response. The histamine concentration and the current change amount, that is, the cell current change amount, have a positive correlation in the range of the histamine concentration of 20 to 200 nM. That is, the concentration of histamine contained in the sample can be determined from the amount of change in the current of the cell.
【0016】図3は血液中のヒスタミンによる細胞の電
流応答を示したものである。ヒスタミン受容体発現卵母
細胞にヒスタミン含有血液を添加するとAに示したよう
な細胞の電流変化がある。一方、ヒスタミンを含まない
血液を添加するとBに示したように電流変化は起こらな
い。つまり、Aで示した電流変化は血液中の他の狭雑物
ではなく、ヒスタミンに反応して引き起こされたもので
ある。すなわち本法では、血液中のヒスタミンを分離・
精製・標識することなく、そのままの形で定量すること
ができる。FIG. 3 shows the current response of cells caused by histamine in blood. When histamine-containing blood is added to histamine receptor-expressing oocytes, there is a change in cell current as shown in A. On the other hand, when blood containing no histamine is added, no current change occurs as shown in B. In other words, the current change indicated by A is not caused by other contaminants in blood, but is caused in response to histamine. That is, in this method, histamine in blood is separated and
It can be quantified as it is without purification and labeling.
【0017】実施例1 図4は本法をアレルギー診断に適用する際の基本プロト
コルを示した図である。採血された全血11に例えばスギ
花粉などの抗原12を一定量添加し、10-30分間程度、37
℃で反応させる。抗原刺激により、血液中好塩基球13よ
りヒスタミン8が放出される。この間にヒスタミン受容
体発現卵母細胞を既知の複数の濃度のヒスタミンで刺激
し、図2と同様な細胞の電流変化量とヒスタミン濃度間
の濃度−応答曲線(検量線)を求めておく。抗原刺激後
の全血をピペットなどで採取し、ヒスタミン受容体発現
細胞を刺激する。その電気的応答量を検量線にあては
め、抗原刺激後の全血に含まれるヒスタミン濃度を定量
する。なおヒスタミン遊離率は、抗原刺激により遊離し
た全血のヒスタミン濃度をA、凍結融解法により血中の
細胞に含まれる全てのヒスタミンを放出させた全血のヒ
スタミン濃度をB、コントロールとして抗原の代わりに
緩衝液を加えて、血中の細胞から自然遊離ヒスタミン濃
度をCとして、(A-C)/Bによって求める。Example 1 FIG. 4 is a diagram showing a basic protocol when the present method is applied to allergy diagnosis. A certain amount of antigen 12 such as cedar pollen is added to the collected whole blood 11, for about 10-30 minutes, 37
React at ° C. Histamine 8 is released from basophils 13 in blood by antigen stimulation. During this period, the histamine receptor-expressing oocytes are stimulated with a plurality of known concentrations of histamine, and a concentration-response curve (calibration curve) between the amount of change in the current of the cells and the histamine concentration is obtained in the same manner as in FIG. Whole blood after antigen stimulation is collected with a pipette or the like to stimulate histamine receptor-expressing cells. The amount of electrical response is fitted to a calibration curve, and the concentration of histamine contained in whole blood after antigen stimulation is quantified. The histamine release rate is the histamine concentration of whole blood released by antigen stimulation, B is the histamine concentration of whole blood released from all histamine contained in blood cells by freeze-thawing method, and B is the control instead of antigen. And the concentration of spontaneously free histamine from the cells in the blood is determined as C by (AC) / B.
【0018】この手法を用いることにより、特開平10-6
2415や特開平10-170514の手法による3時間、ELISA法に
よる4時間と比較して測定時間が30分程度と短かくな
る。また作業行程も4ステップと他の手法と比較してき
わめて少ない。さらにヒスタミン濃度を直接測定するた
めの標準ヒスタミン以外の試薬類を必要とせず、コスト
の削減が図れる点も特徴の一つである。By using this method, Japanese Patent Application Laid-Open
The measurement time is as short as about 30 minutes as compared with 3 hours according to the method of 2415 or JP-A-10-170514 and 4 hours according to the ELISA method. Also, the number of work steps is four steps, which is extremely small compared to other methods. Another feature is that no reagents other than the standard histamine for directly measuring the histamine concentration are required, and the cost can be reduced.
【0019】実施例2 図5は本法を用いて全血中及び抗原(スギ花粉)刺激に
より血液中の細胞から血漿中に遊離したヒスタミン濃度
を定量した結果である。遊離ヒスタミン量から緩衝液の
みで刺激した際に遊離したヒスタミン量(コントロー
ル)分を差し引いた値を、全血を凍結融解して得られた
ヒスタミン量で割ることにより、抗原刺激によるヒスタ
ミン遊離率を求めた。一般のヒスタミン遊離試験におい
て特定の抗原刺激によるヒスタミン遊離率が10%以上で
あるとき、その検体のアレルギー反応はポジティブであ
ると考えられている。つまり検体1と3はスギ花粉に対し
てアレルギー反応が起こっていると考えられる。これら
の結果は従来法であるHRT試験および被験者の自覚症状
と一致した。Example 2 FIG. 5 shows the results of quantification of the concentration of histamine released from cells in the blood into plasma by stimulation with antigen (cedar pollen) in whole blood and using this method. The value obtained by subtracting the amount of histamine (control) released when stimulated with the buffer alone from the amount of free histamine was divided by the amount of histamine obtained by freezing and thawing whole blood to obtain the histamine release rate by antigen stimulation. I asked. When the histamine release rate by a specific antigen stimulation is 10% or more in a general histamine release test, the allergic reaction of the sample is considered to be positive. That is, it is considered that the specimens 1 and 3 have an allergic reaction to cedar pollen. These results were consistent with the conventional HRT test and the subject's subjective symptoms.
【0020】実施例3 図6に全血を用いたアレルギー検査を行うための実際の
反応容器を示す。本容器は卵母細胞を固定しガラス電極
3、4で電流変化を計測する部分、卵母細胞を一定容量の
緩衝液に浸すためと、容器内部を洗浄するための排水路
の部分、さらにアレルギー反応を起こさせた血液を卵母
細胞に添加する部分からなる。EXAMPLE 3 FIG. 6 shows an actual reaction vessel for performing an allergy test using whole blood. This container holds oocytes and uses a glass electrode
Measure the current change in steps 3 and 4; immerse the oocytes in a fixed volume of buffer solution; drain the water to wash the inside of the container; and transfer allergic blood to the oocytes. It consists of a part to be added.
【0021】次に、実際の測定方法に関して詳細に説明
する。水路14より卵母細胞用の緩衝液を流し容器を満た
し、その後水路15より真空ポンプ等で余分な液を排出す
る。これにより卵母細胞を浸すために十分な液を常に一
定量に保つことができる。ヒスタミン受容体のmRNAを導
入後2-3日培養した卵母細胞2をその溶液に静かに沈め、
卵母細胞用穴16に固定する。ガラス電極3を卵母細胞に
刺し卵母細胞の膜電位をチェックする。次に、ガラス電
極4を卵母細胞に刺し、膜電位を-60mVに固定する。Next, the actual measuring method will be described in detail. A buffer solution for oocytes is allowed to flow through the water channel 14 to fill the container, and then an excess liquid is discharged from the water channel 15 by a vacuum pump or the like. Thus, a constant amount of liquid sufficient to soak the oocyte can be always maintained. Oocytes 2 cultured 2-3 days after introduction of the histamine receptor mRNA are gently submerged in the solution,
It is fixed in the oocyte hole 16. The glass electrode 3 is inserted into the oocyte to check the membrane potential of the oocyte. Next, the glass electrode 4 is stabbed into the oocyte, and the membrane potential is fixed at -60 mV.
【0022】その後図4で示した操作により調整した全
血11をピペット9で卵母細胞2に静かに添加する。全血11
にはヒスタミン遊離反応により放出されたヒスタミン8
が含まれている。そのヒスタミンが卵母細胞2を刺激す
ることにより、電流変化を測定することができる。その
電流変化量の大きさより全血中のヒスタミン量を定量す
ることができる。Thereafter, the whole blood 11 prepared by the operation shown in FIG. 4 is gently added to the oocyte 2 with a pipette 9. Whole blood 11
Contains histamine 8 released by histamine release reaction
It is included. When the histamine stimulates the oocyte 2, the current change can be measured. The amount of histamine in whole blood can be determined from the magnitude of the current change.
【0023】ヒスタミン遊離反応を起こさせた全血をピ
ペット9で添加する方法以外に、本容器の一部に全血の
ヒスタミン遊離反応をするための部品を取付け、全血の
ヒスタミン遊離反応からその反応に伴なうヒスタミン放
出量の定量までを連続的に計測することも可能である。
5-20mLの微量な血液をガラスキャピラリー17に直接注入
する。このガラスキャピラリー17の内壁にはすでに花粉
などの抗原12がコートしてある。そのガラスキャピラリ
ー17を卵母細胞反応容器に付属されているヒーター部分
18に刺し込む。このヒーター部分18は温度制御部(図
示せず)により所定の温度に設定されている。そのガラ
スキャピラリー17を37℃で約30分間ほど温め、ヒスタミ
ン遊離反応を起こさせる。本実施例ではガラスキャピラ
リー17を37℃に温めたが、ヒスタミン遊離反応を起こ
る30〜45℃範囲であればよい。その反応後、コック
19を開きガラスキャピラリー17の内部の全血11を卵母細
胞2に送付手段(図示せず)により添加し電流反応を測
定する。In addition to the method of adding the whole blood that has undergone the histamine release reaction with a pipette 9, a part for performing the histamine release reaction of whole blood is attached to a part of the container, and the histamine release reaction of whole blood It is also possible to continuously measure up to the quantification of the amount of histamine release accompanying the reaction.
A small amount of 5-20 mL of blood is directly injected into the glass capillary 17. The inner wall of the glass capillary 17 is already coated with the antigen 12 such as pollen. Heat the glass capillary 17 with the oocyte reaction vessel
Stab at 18. The heater section 18 is set at a predetermined temperature by a temperature control section (not shown). The glass capillary 17 is warmed at 37 ° C. for about 30 minutes to cause a histamine release reaction. In this embodiment, the glass capillary 17 is heated to 37 ° C., but may be in the range of 30 to 45 ° C. at which the histamine release reaction occurs. After that reaction, cock
19 is opened, the whole blood 11 inside the glass capillary 17 is added to the oocyte 2 by sending means (not shown), and the current response is measured.
【0024】一連の卵母細胞の反応を測定した後、ガラ
ス電極3、4を卵母細胞2から抜き取り、排水路20から吸
引により溶液と共に卵母細胞2を排出する。水路15より
洗浄水を流し排水路20より排出する。これらの操作を3-
4回繰り返し、容器内部の汚れを流す。After measuring a series of reactions of the oocyte, the glass electrodes 3 and 4 are extracted from the oocyte 2 and the oocyte 2 is discharged together with the solution from the drainage channel 20 by suction. Wash water flows from the water channel 15 and is discharged from the drain channel 20. Perform these operations 3-
Repeat 4 times to remove dirt from inside the container.
【0025】[0025]
【発明の効果】本発明ではヒスタミンの検出にヒスタミ
ン受容体発現細胞を用いることにより、標識化合物とし
てではなく、ヒスタミンを直接定量できることから作業
工程及び用いる試薬数を最小限にすることができる。そ
のため、コストおよび測定時間を削減することが可能に
なる。さらにこれらの特徴より、全血中の遊離ヒスタミ
ンを前処理なしに短時間で定量できる。According to the present invention, by using histamine receptor-expressing cells for histamine detection, histamine can be directly quantified, not as a labeling compound, so that the number of working steps and the number of reagents used can be minimized. Therefore, cost and measurement time can be reduced. Further, from these characteristics, free histamine in whole blood can be quantified in a short time without any pretreatment.
【図1】ヒスタミン受容体発現卵母細胞を用いたヒスタ
ミン定量法の概略図。FIG. 1 is a schematic diagram of a histamine quantification method using histamine receptor-expressing oocytes.
【図2】ヒスタミン濃度と細胞応答の関係(検量線)を
示す図。FIG. 2 is a graph showing the relationship between histamine concentration and cell response (calibration curve).
【図3】血液中のヒスタミンによる細胞応答を示す図。FIG. 3 is a diagram showing a cellular response to histamine in blood.
【図4】ヒスタミン遊離試験法プロトコルを示す図。FIG. 4 shows the histamine release test protocol.
【図5】本法による血中ヒスタミン濃度の測定値を示す
表形式の図。FIG. 5 is a tabular diagram showing measured values of blood histamine concentration according to the present method.
【図6】アレルギー検査用容器を示す図。FIG. 6 is a view showing a container for an allergy test.
1・・・本体部分、2・・・ヒスタミン受容体発現卵母細胞、3・
・・ガラス電極、4・・・ガラス電極、5・・・外部電極、6・・・差
動増幅器、7・・・記録装置、8・・・ヒスタミン、9・・・ピペッ
ト、10・・・細胞応答、11・・・血液(全血)、12・・・抗原な
どヒスタミン遊離物質、13・・・好塩基球、14・・・緩衝液注
水溝、15・・・水路、16・・・卵母細胞用穴、17・・・ガラスキ
ャピラリー、18・・・ヒーター部分、19・・・コック、20・・・
排水溝。1 ... body part, 2 ... histamine receptor-expressing oocytes, 3.
..Glass electrode, 4 ... Glass electrode, 5 ... External electrode, 6 ... Differential amplifier, 7 ... Recording device, 8 ... Histamine, 9 ... Pipette, 10 ... Cell response, 11: Blood (whole blood), 12: Histamine-releasing substance such as antigen, 13: Basophil, 14: Buffer injection groove, 15: Water channel, 16 ... Hole for oocyte, 17 ・ ・ ・ Glass capillary, 18 ・ ・ ・ Heating part, 19 ・ ・ ・ cock, 20 ・ ・ ・
Drains.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) G01N 33/483 G01N 33/49 Z 33/49 33/53 Q 33/53 27/46 336G Fターム(参考) 2G045 AA01 BA13 BB14 BB22 BB46 BB51 DA71 FB03 GC20 JA07 4B029 AA07 BB11 CC03 FA12 FA15 4B063 QA01 QA19 QQ03 QQ61 QR77 QS39 QX04 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) G01N 33/483 G01N 33/49 Z 33/49 33/53 Q 33/53 27/46 336G F term (reference) 2G045 AA01 BA13 BB14 BB22 BB46 BB51 DA71 FB03 GC20 JA07 4B029 AA07 BB11 CC03 FA12 FA15 4B063 QA01 QA19 QQ03 QQ61 QR77 QS39 QX04
Claims (11)
タミン依存的反応を定量的に計測し、試料中に含まれる
ヒスタミンを定量することを特徴とするヒスタミン計測
方法。1. A method for measuring histamine comprising quantitatively measuring a histamine-dependent reaction of an oocyte having a histamine receptor, and quantifying histamine contained in a sample.
とする請求項1記載のヒスタミン計測方法。2. The method for measuring histamine according to claim 1, wherein unlabeled histamine is detected.
ることを特徴とする請求項1記載のヒスタミン計測方
法。3. The method for measuring histamine according to claim 1, wherein unpurified histamine is detected from the contaminants.
卵母細胞を用いて、血液中に含まれるヒスタミンを検出
し、定量することを特徴とする請求項1〜3記載のヒスタ
ミン計測方法。4. The method for measuring histamine according to claim 1, wherein histamine contained in blood is detected and quantified by using a histamine receptor-expressing oocyte in the histamine detecting section.
と、前記容器から送廃液を除去するチューブと、を有
し、測定対象の血液と抗原とによりヒスタミン遊離反応
を起こし、この反応液を前記容器に添加し、前記卵母細
胞の電流量の変化を測定し、前記ヒスタミン遊離反応で
遊離したヒスタミン量を求めることを特徴とするヒスタ
ミン計測装置。5. A container having a hole for holding an oocyte, and a tube for removing a waste liquid from the container, wherein a histamine release reaction is caused by the blood to be measured and the antigen, A histamine measuring device comprising: adding a liquid to the container; measuring a change in the amount of current of the oocyte; and determining an amount of histamine released by the histamine release reaction.
前記反応液を添加することを特徴とする請求項5記載の
ヒスタミン計測装置。6. The histamine measuring apparatus according to claim 5, wherein the reaction solution is added from above the container using a flow channel or a pipette.
有細胞からヒスタミン遊離反応を引き起こさせる反応槽
をさらに有することを特徴とする請求項5および6記載の
ヒスタミン計測装置。7. The histamine measuring apparatus according to claim 5, further comprising a reaction tank for causing a histamine release reaction from histamine-containing cells such as blood, leukocytes, and mast cells.
液する送液手段を有することを特徴とした請求項7記載
のヒスタミン計測装置。8. The histamine measuring device according to claim 7, further comprising a liquid sending means for sending the reaction solution from the reaction tank to the container.
と、壁面に抗原が固定されたキャピラリーと、卵母細胞
が保持された前記容器に前記キャピラリー内の反応液を
送液する送液手段と、前記容器から送廃液を除去するチ
ューブと、を有し、前記キャピラリーに測定対象の血液
を流し、前記キャピラリー内でヒスタミン遊離反応を起
こし、前記卵母細胞の電流量の変化を測定し、前記キャ
ピラリー内で遊離したヒスタミン量を求めることを特徴
とするヒスタミン計測装置。9. A container having a hole for holding an oocyte, a capillary in which an antigen is fixed on a wall surface, and a pump for sending a reaction solution in the capillary to the container in which an oocyte is held. A liquid means, and a tube for removing waste liquid from the container, causing the blood to be measured to flow through the capillary, causing a histamine release reaction in the capillary, and measuring a change in the amount of current of the oocyte. A histamine measuring device for determining an amount of histamine released in the capillary.
る温度制御手段を、さらに有することを特徴とする請求
項9記載のヒスタミン計測装置。10. The histamine measuring apparatus according to claim 9, further comprising temperature control means for controlling said capillary at a predetermined temperature.
C以下であることを特徴とする請求項10記載のヒスタ
ミン計測装置。11. The predetermined temperature is 30 ° C. or more and 45 ° or more.
The histamine measurement device according to claim 10, wherein the histamine measurement device is not more than C.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18474099A JP3707303B2 (en) | 1999-06-30 | 1999-06-30 | Histamine measuring method and histamine measuring device |
US09/604,512 US6268121B1 (en) | 1999-06-30 | 2000-06-27 | Histamine measuring apparatus and a histamine measuring method |
US09/788,340 US6329154B2 (en) | 1999-06-30 | 2001-02-21 | Histamine measuring apparatus and a histamine measuring method |
US09/788,481 US6338960B2 (en) | 1999-06-30 | 2001-02-21 | Histamine measuring apparatus and a histamine measuring method |
US09/788,482 US6329194B2 (en) | 1999-06-30 | 2001-02-21 | Histamine measuring apparatus and a histamine measuring method |
US09/788,361 US6277559B2 (en) | 1999-06-30 | 2001-02-21 | Histamine measuring apparatus and a histamine measuring method |
US09/843,866 US6337178B2 (en) | 1999-06-30 | 2001-04-30 | Histamine measuring apparatus and a histamine measuring method |
US09/984,614 US6420168B1 (en) | 1999-06-30 | 2001-10-30 | Histamine measuring apparatus and a histamine measuring method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18474099A JP3707303B2 (en) | 1999-06-30 | 1999-06-30 | Histamine measuring method and histamine measuring device |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001013136A true JP2001013136A (en) | 2001-01-19 |
JP3707303B2 JP3707303B2 (en) | 2005-10-19 |
Family
ID=16158535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18474099A Expired - Fee Related JP3707303B2 (en) | 1999-06-30 | 1999-06-30 | Histamine measuring method and histamine measuring device |
Country Status (2)
Country | Link |
---|---|
US (7) | US6268121B1 (en) |
JP (1) | JP3707303B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100799292B1 (en) | 2006-06-08 | 2008-01-29 | 허관용 | Apparatus and method for detecting allergen |
WO2017039356A1 (en) * | 2015-09-01 | 2017-03-09 | (주) 원메디칼 | Allergen detection apparatus using electrochemical detection method |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3707303B2 (en) * | 1999-06-30 | 2005-10-19 | 株式会社日立製作所 | Histamine measuring method and histamine measuring device |
JP3525837B2 (en) * | 1999-12-24 | 2004-05-10 | 株式会社日立製作所 | Automatic electrophysiological measuring device and automatic electrophysiological measuring method |
US7011939B2 (en) * | 2000-03-22 | 2006-03-14 | Abbott Laboratories | Apparatus and method for electrophysiological testing |
US20040132174A1 (en) * | 2000-03-28 | 2004-07-08 | Smith Allan Joseph Hilling | Perfusion incubator |
AUPQ653000A0 (en) * | 2000-03-28 | 2000-04-20 | Cook Incorporated | Perfusion incubator |
US6461860B2 (en) * | 2001-01-25 | 2002-10-08 | Axon Instruments, Inc. | Alignment mechanism for two-electrode voltage-clamp perfusion chamber for electrophysiological testing of oocytes |
US6815197B2 (en) * | 2001-02-16 | 2004-11-09 | Multi Channel System Mcs Gmbh | Apparatus for conducting electrophysiological measurements on cells |
US7745180B2 (en) | 2002-04-24 | 2010-06-29 | Hitachi Chemical Co., Ltd. | Device and method for high-throughput quantification of mRNA from whole blood |
US7407781B2 (en) * | 2002-05-08 | 2008-08-05 | Wyeth | Oocyte recording chamber |
US20040003679A1 (en) * | 2002-07-05 | 2004-01-08 | David Ide | Apparatus and method for in vitro recording and stimulation of cells |
DE10349492B4 (en) * | 2003-10-23 | 2007-01-11 | Hering, Steffen, Univ. Prof. | Perfusion device for treatment and examination of an object in a liquid |
US20070231879A1 (en) * | 2006-03-30 | 2007-10-04 | Steffen Hering | Perfusion device for the treatment and examination of an object in a liquid |
EP2058657A1 (en) * | 2007-10-31 | 2009-05-13 | Bayer Schering Pharma Aktiengesellschaft | Method for determining bioactivity of molecules |
US8420054B2 (en) * | 2009-09-18 | 2013-04-16 | The Procter & Gamble Company | Noninvasive method for measuring histamine from skin as an objective measurement of itch |
EP2931854A1 (en) | 2012-12-14 | 2015-10-21 | The Procter & Gamble Company | Fragrance materials |
JP6657974B2 (en) * | 2016-01-12 | 2020-03-04 | トヨタ紡織株式会社 | Metal-resin integrated molded product and method of manufacturing the same |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4343782A (en) * | 1978-04-20 | 1982-08-10 | Shapiro Howard M | Cytological assay procedure |
US4629706A (en) * | 1982-02-01 | 1986-12-16 | Miles Laboratories, Inc. | Method for determining allergic sensitivity |
US4544629A (en) * | 1982-11-19 | 1985-10-01 | Minnesota Mining And Manufacturing Company | Receptor-based histamine assay |
SE461660B (en) * | 1983-04-19 | 1990-03-12 | Bio Instructa Labkonsult | PROCEDURE FOR ANALYSIS OF RECEPTOR ACTIVITIES ON CELLS |
EP0428606B1 (en) | 1988-08-11 | 1994-10-19 | Allergifonden Af 1981 | Method and means for allergy diagnosis |
US5098831A (en) * | 1988-08-11 | 1992-03-24 | Allergifonden Af 1981 | Method and means for allergy diagnosis |
US5468650A (en) * | 1988-10-17 | 1995-11-21 | A/S Lundbeck Export Division Ltd. | Class microfiber histamine assay device |
CA2027694C (en) * | 1989-10-20 | 2002-03-05 | Tadashi Matsunaga | Process and apparatus for detecting sensitized leukocyte or antigen |
JP3068879B2 (en) * | 1991-03-09 | 2000-07-24 | フマキラー株式会社 | Refined mite allergen |
US5460945A (en) * | 1991-05-30 | 1995-10-24 | Center For Blood Research, Inc. | Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response |
JP2717745B2 (en) * | 1992-03-18 | 1998-02-25 | 株式会社モリテックス | A method for rapid quantification of histamine. |
US5437861A (en) * | 1993-03-16 | 1995-08-01 | Applied Immune Sciences, Inc. | Removal of selected factors from whole blood or its components; and prevention and treatment of septic shock syndrome |
JP3272476B2 (en) | 1993-05-19 | 2002-04-08 | 塩野義製薬株式会社 | Fluorescent HPLC determination of bioactive amines |
US5849719A (en) * | 1993-08-26 | 1998-12-15 | The Regents Of The University Of California | Method for treating allergic lung disease |
GB9501683D0 (en) * | 1995-01-27 | 1995-03-15 | Glaxo Group Ltd | Substances and their uses |
AU1059997A (en) * | 1995-11-08 | 1997-05-29 | Trustees Of Boston University | Cellular physiology workstations for automated data acquisition and perfusion control |
JPH10170514A (en) | 1996-12-06 | 1998-06-26 | Asahi Chem Ind Co Ltd | Method for measuring fluorescent intensity of histamine |
JP3697852B2 (en) | 1997-09-08 | 2005-09-21 | 株式会社日立製作所 | Measuring system |
JP3707303B2 (en) * | 1999-06-30 | 2005-10-19 | 株式会社日立製作所 | Histamine measuring method and histamine measuring device |
-
1999
- 1999-06-30 JP JP18474099A patent/JP3707303B2/en not_active Expired - Fee Related
-
2000
- 2000-06-27 US US09/604,512 patent/US6268121B1/en not_active Expired - Fee Related
-
2001
- 2001-02-21 US US09/788,482 patent/US6329194B2/en not_active Expired - Fee Related
- 2001-02-21 US US09/788,340 patent/US6329154B2/en not_active Expired - Fee Related
- 2001-02-21 US US09/788,481 patent/US6338960B2/en not_active Expired - Fee Related
- 2001-02-21 US US09/788,361 patent/US6277559B2/en not_active Expired - Fee Related
- 2001-04-30 US US09/843,866 patent/US6337178B2/en not_active Expired - Fee Related
- 2001-10-30 US US09/984,614 patent/US6420168B1/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100799292B1 (en) | 2006-06-08 | 2008-01-29 | 허관용 | Apparatus and method for detecting allergen |
WO2017039356A1 (en) * | 2015-09-01 | 2017-03-09 | (주) 원메디칼 | Allergen detection apparatus using electrochemical detection method |
Also Published As
Publication number | Publication date |
---|---|
US20010005580A1 (en) | 2001-06-28 |
US6337178B2 (en) | 2002-01-08 |
US6268121B1 (en) | 2001-07-31 |
US6329194B2 (en) | 2001-12-11 |
US6277559B2 (en) | 2001-08-21 |
US20010006774A1 (en) | 2001-07-05 |
US6329154B2 (en) | 2001-12-11 |
US20010016313A1 (en) | 2001-08-23 |
US6338960B2 (en) | 2002-01-15 |
JP3707303B2 (en) | 2005-10-19 |
US6420168B1 (en) | 2002-07-16 |
US20020025574A1 (en) | 2002-02-28 |
US20010004524A1 (en) | 2001-06-21 |
US20010004525A1 (en) | 2001-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001013136A (en) | Histamine measuring method and histamine measuring device | |
US5415758A (en) | Method and apparatus for electro-elution of biological molecules | |
CN108872582A (en) | A kind of aptamer sensor based on DNAWalker, preparation method and applications | |
Liu et al. | Determination of catecholamines by CE with direct chemiluminescence detection | |
CN106755399A (en) | A kind of I types neurofibromatosis Disease-causing gene mutation and the Etiologic reagent based on this gene mutation | |
US20230042710A1 (en) | Electrochemical proximity assay | |
CN108896750A (en) | A kind of preparation method and purposes of BSA-Au/Ag NCs/OPD/HRP proportional-type fluorescent optical sensor | |
JP2002340857A (en) | Device and method for gene diagnosis | |
Pohanka et al. | Serological diagnosis of tularemia in mice using the amperometric immunosensor | |
JP3201867B2 (en) | Nucleic acid analysis method | |
CN109628576A (en) | Detect the primer and method of FGD1 gene mutation | |
JP3697852B2 (en) | Measuring system | |
Markovic et al. | Quantitation of FcγRII mRNA in platelets and megakaryoblastic cell lines by a new method of in situ hybridization | |
JP2002174636A (en) | Device and method for measuring number and concentration of microorganism | |
Yanagawa et al. | On-chip base sequencing using a two-stage reaction-control scheme: 3.6-times-faster and 1/100-reduced-data-volume ISFET-based DNA sequencer | |
JP2002340859A (en) | Device and method for gene diagnosis | |
TWI294968B (en) | ||
CN106680337B (en) | Quantitative detection method of heparin | |
CN111693593A (en) | Silicon dioxide uniform pore membrane for H in blood2Electrochemical luminescence detection method of S | |
JP2002340858A (en) | Device and method for gene diagnosis | |
US20210338211A1 (en) | Ocular inserts with analyte capture and release agents | |
JP2955003B2 (en) | Sensitized white blood cell detection method | |
EP4242658A1 (en) | A system and method for biomolecule detection | |
Nguyen et al. | The preparation of a fine tip calcium ion selective electrode | |
JP2002333444A (en) | Apparatus and method for gene diagnosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040531 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040608 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040701 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041207 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041213 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050712 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050725 |
|
LAPS | Cancellation because of no payment of annual fees |